Skip to main content
Quest Diagnostics

Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use

Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use

Authors: Jones JM, Aldarweesh F, Aqui N, Bobr A, Brunker P, Covington ML, Guarente J, Hagar R, Karafin M, Lamba DS, Lee G, Lu W, Mack EA, Muthur G, Nazli S, Olaniyan H, Onyenekwu CP, Raval JS, Setya D, Tanhehco YC, Thant M, Vivero A, Wu Y, Wong ECC, Yurtsever N, Zheng Y, Shi PA, Webb J

Citation: J Clin Apher. 2026 Jun;41(3):e70146. doi: 10.1002/jca.70146.

Specialties: Coagulation, Hematology

Related content

Test FAQ
Sickle Cell Screen
Conference Presentation
Application of Automated Red Cell Exchange in Patients with Sickle Cell Anemia: An International Practice Survey
Publication
Trpv1 and Trpa1 are not essential for Psickle-like activity in red cells of the SAD mouse model of sickle cell disease
Publication
Maternal Red Blood Cell Alloimmunization Prevalence in the United States
Publication
Magnesium homeostasis in deoxygenated sickle erythrocytes is modulated by endothelin-1 via Na+ /Mg2+ exchange

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.